Hiscox Ltd Share Price London S.E.
Equities
BMG4593F1207
Property & Casualty Insurance
End-of-day quote
Other stock markets
|
||
- GBX | - |
08/05 | UBS raises Centrica to 'buy' from 'neutral | AN |
07/05 | AstraZeneca target raised; Antofagasta lowered | AN |
Sales 2024 * | 3.92B 4.9B 409B | Sales 2025 * | 4.28B 5.36B 447B | Capitalization | 4.07B 5.09B 425B |
---|---|---|---|---|---|
Net income 2024 * | 470M 588M 49.14B | Net income 2025 * | 505M 632M 52.8B | EV / Sales 2024 * | 1.04 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.95 x |
P/E ratio 2024 * |
8.7
x | P/E ratio 2025 * |
7.98
x | Employees | - |
Yield 2024 * |
2.74% | Yield 2025 * |
3.03% | Free-Float | 92.33% |
Latest transcript on Hiscox Ltd
Managers | Title | Age | Since |
---|---|---|---|
Hamayou Hussain
CEO | Chief Executive Officer | 51 | 22/16/22 |
Paul Cooper
DFI | Director of Finance/CFO | 52 | 12/22/12 |
Stéphane Flaquet
COO | Chief Operating Officer | - | 01/10/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | 16/17/16 | |
Anne MacDonald
BRD | Director/Board Member | 68 | 20/15/20 |
Colin Keogh
BRD | Director/Board Member | 69 | 19/15/19 |
1st Jan change | Capi. | |
---|---|---|
+44.94% | 64.43B | |
+18.24% | 53.17B | |
+14.70% | 50.04B | |
+23.38% | 45.58B | |
+34.71% | 37.42B | |
+12.18% | 29.85B | |
+57.01% | 29.52B | |
+28.51% | 26.24B | |
+16.36% | 21.48B |